Acer Therapeutics Inc. Quarterly Depreciation in USD from Q1 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Acer Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2012 to Q1 2023.
  • Acer Therapeutics Inc. Depreciation for the quarter ending March 31, 2023 was $15.5K, a 24.6% decline year-over-year.
  • Acer Therapeutics Inc. annual Depreciation for 2022 was $66K, a 6.88% decline from 2021.
  • Acer Therapeutics Inc. annual Depreciation for 2021 was $70.9K, a 0.14% increase from 2020.
  • Acer Therapeutics Inc. annual Depreciation for 2020 was $70.8K, a 21.5% increase from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $15.5K -$5.06K -24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $20.6K +$5.97K +40.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $14.6K -$3.08K -17.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $17.7K +$8.16K +85.5% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-11-19
Q1 2019 $9.55K +$3.32K +53.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $6.22K +$5.32K +588% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $905 -$71.7K -98.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 $72.6K -$24.4K -25.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q1 2015 $97K +$1.4K +1.46% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 $95.6K +$17.3K +22.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q1 2013 $78.3K +$11K +16.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q1 2012 $67.4K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.